NewLink Genetics Corp. (NLNK) Financials Nov 20, 2014, 7:57 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for NewLink Genetics Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 934,000 2.08M 1.87M 1.69M 1.09M
Cost of Goods Sold (COGS) incl. D&A 303,000 655,000 - - 891,000
COGS excluding D&A 0 0 - - 0
Depreciation & Amortization Expense 303,000 655,000 687,000 788,000 891,000
Depreciation 303,000 655,000 687,000 788,000 891,000
Amortization of Intangibles 0 0 0 0 0
Gross Income 631,000 1.42M - - 202,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 10.98M 18.09M 19.41M 24.16M 31.34M
Research & Development 7.58M 12.67M 14.42M 17.84M 22.71M
Other SG&A 3.4M 5.42M 4.99M 6.32M 8.63M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 19,000 71,000 5,000 (38,000) 112,000
Non-Operating Interest Income 132,000 75,000 11,000 14,000 12,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 9,000 47,000 42,000 38,000 33,000
Gross Interest Expense 9,000 47,000 42,000 38,000 33,000
Interest Capitalized 0 0 0 0 0
Pretax Income (10.21M) (16.56M) (18.25M) (23.32M) (31.05M)
Income Tax 0 0 (160,000) 0 130,000
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 160,000 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (10.21M) (16.56M) (18.09M) (23.32M) (31.18M)
Minority Interest Expense (233,000) (349,000) (1,000) 0 0
Net Income (9.97M) (16.21M) (18.09M) (23.32M) (31.18M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (9.97M) (16.21M) (18.09M) (23.32M) (31.18M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (9.97M) (16.21M) (18.09M) (23.32M) (31.18M)
EPS (Basic) (0.55) (0.90) (2.98) (1.12) (1.23)
Basic Shares Outstanding 18.02M 18.02M 6.06M 20.78M 25.28M
EPS (Diluted) (0.55) (0.90) (2.98) (1.12) (1.23)
Diluted Shares Outstanding 18.02M 18.02M 6.06M 20.78M 25.28M
EBITDA (10.05M) (16.01M) (17.54M) (22.47M) (30.25M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for NewLink Genetics Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 934,000 2.08M 1.87M 1.69M 1.09M
Cost of Goods Sold (COGS) incl. D&A 303,000 655,000 - - 891,000
COGS excluding D&A 0 0 - - 0
Depreciation & Amortization Expense 303,000 655,000 687,000 788,000 891,000
Depreciation 303,000 655,000 687,000 788,000 891,000
Amortization of Intangibles 0 0 0 0 0
Gross Income 631,000 1.42M - - 202,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 10.98M 18.09M 19.41M 24.16M 31.34M
Research & Development 7.58M 12.67M 14.42M 17.84M 22.71M
Other SG&A 3.4M 5.42M 4.99M 6.32M 8.63M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 19,000 71,000 5,000 (38,000) 112,000
Non-Operating Interest Income 132,000 75,000 11,000 14,000 12,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 9,000 47,000 42,000 38,000 33,000
Gross Interest Expense 9,000 47,000 42,000 38,000 33,000
Interest Capitalized 0 0 0 0 0
Pretax Income (10.21M) (16.56M) (18.25M) (23.32M) (31.05M)
Income Tax 0 0 (160,000) 0 130,000
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 160,000 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (10.21M) (16.56M) (18.09M) (23.32M) (31.18M)
Minority Interest Expense (233,000) (349,000) (1,000) 0 0
Net Income (9.97M) (16.21M) (18.09M) (23.32M) (31.18M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (9.97M) (16.21M) (18.09M) (23.32M) (31.18M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (9.97M) (16.21M) (18.09M) (23.32M) (31.18M)
EPS (Basic) (0.55) (0.90) (2.98) (1.12) (1.23)
Basic Shares Outstanding 18.02M 18.02M 6.06M 20.78M 25.28M
EPS (Diluted) (0.55) (0.90) (2.98) (1.12) (1.23)
Diluted Shares Outstanding 18.02M 18.02M 6.06M 20.78M 25.28M
EBITDA (10.05M) (16.01M) (17.54M) (22.47M) (30.25M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
